“Our employees are our greatest asset. At CROMSOURCE, we are all incredibly passionate about improving patient lives, even in this difficult and complex time. We are continuing to pursue our values and mission while putting in place the necessary actions to continue daily activity while being compliant with the indications of local Health Authorities.
We want to thank all of our amazing colleagues who are making every effort to maintain the continuity of our activities to ensure we are always there for our clients, investigators and patients. We never forget that at the core of our business are the patients whose interest and safety must always come first.”
Dr. Oriana Zerbini
As the global impact of COVID-19 increases, our top priorities are the safety of our patients, clients and employees while keeping business continuity.
“To effectively meet the developing challenges that COVID-19 brings requires teamwork.
At CROMSOURCE, the Executive Management Team lead our COVID-19 Task Force and are working together to promote the safety and wellbeing of our colleagues, assure the health and rights of patients participating in our research projects, and implement the latest regulatory guidance applicable to the conduct of our work.
Our strong IT infrastructure ensures that our teams are able to maintain their activities while fully respecting advice from local authorities about remaining at home. We may be working differently in these days, but we remain as one strong team supporting our clients to develop life changing therapies for patients.”
Chief Operating Officer
Chief Human Resources Officer
Chief Commercial Officer
“The CROMSOURCE Human Resources department is closely following the local government guidelines regarding COVID-19. Since the beginning of the outbreak we have been updating our employees regularly, we expanded remote working, and have created collaborative initiatives, like sharing tips and tricks for working from home and pictures of their homebased environments, to bring us together while we are all distant. In this difficult time it’s important to keep our colleagues motivated and to search for the best solutions in order to keep our business up and running. Keep the ‘one team’ mentality to get through this together!”
Human Resources Director
“With the challenges that COVID-19 brings us in our new daily routines and work schedules, Techorizon has been facing these challenges with solutions. Techorizon allows all of our customers to continue their business activities completely from home without any interruption, as local authorities require.
Our technology and collaboration tools allow us to continue at full capacity with our eCRF services dedicated to clinical research and allow us to start new studies without any impact on study timelines.”
Techorizon Managing Director
We may be working differently in these days, but we remain as one strong team supporting our clients to develop life changing therapies.
How we can help fight COVID-19
Flexibility when it matters most
With the day-to-day changes that COVID-19 is bringing to healthcare and the world it is important to stay flexible and agile. As a mid-sized CRO we are positioned to provide the flexibility needed and the best support to our clients to be successful in this fight.
What we offer: expertise and knowledge
With experience that spans nearly 25 years, the core of our business has always been driven by the passion for bringing life-saving drugs and devices to those who need them. We are dedicated to help fight COVID-19 with knowledge of regulatory affairs and our experienced clinical operations teams. In addition, we can also offer fast additional resources and support via our flexible resourcing department – TalentSource Life Sciences.
We have many challenges to face to offset disruption:
Regulatory knowledge and guidance
With our understanding of regulatory systems throughout Europe and the US, our regulatory team is keeping our clients up-to-date on these rapidly changing regulatory landscapes. We are actively monitoring these changes while providing our clients with practical advice to help continue their projects.
Every clinical trial is different and only the project managers know every aspect of their trial. Therefore regulators have asked that detailed risk assessments be performed, making the safety of trial participants their top priority. These risk assessments allow for us to identify the potential disruptions that COVID-19 could cause. With the knowledge of our clinical operations and compliance teams we are able to find these potential disruptions and prepare processes and plan ahead of time to comply with important regulations.
“With the impacts of COVID-19, focused risk assessments and a willingness to rapidly implement innovative mitigation strategies are vital for the safety of patients and success of ongoing clinical trials. It is our duty to patients and our clients to continue our management of research into new treatments and medical devices as far as possible, while staying compliant with regulatory guidelines.”
Kerry Dyson, Chief Operating Officer.
Our experienced clinical operations team is prepared to provide the flexibility that each trial needs to be successful and compliant during this unprecedented time. We have taken the appropriate steps to virtualize our clinical trials and to monitor sites remotely.
With the daily changes that are arising due to this disease we understand that protocol amendments may need to be considered and the importance of site engagement. We are in constant contact with our investigators to keep them up-to-date on any changes and keep them motivated while participating in the trial virtually.
We are prepared to provide solutions to any statistical analysis challenges that may arise due to COVID-19, we are committed to collect accurate and reliable data that each project needs.
As the pandemic and disease evolves we are taking the necessary precautions while evaluating our overall clinical portfolio and study designs.
Flexible Resourcing Solutions
We have strong expertise in supporting clients in finding staff for any role within the clinical and medical devices fields. In this situation with all the challenges that a pandemic could create we are being called upon to be even faster in supporting our clients. For example, we had a request for coordinators to work at specific hospitals, in multiple countries and we found people in 2 days, who had immediate capacity; In another example, we needed someone to work on a COVID-19 study and we found the perfect match within 1 week.
Due to our excellent recruitment database, we find people with varying technical skill-sets, specific therapy area experience and specialist language capabilities, in a very quick timeframes. Providing fast, cost effective, temporary support to new and existing clients.
Providing digital solutions
With our technological advancements we are able to provide virtual solutions to meet the needs during this time. This ensures that we are keeping patients safe while continuing to progress with our life-saving research.
Considerations for Managing COVID-19 Studies
Rapid study start-up is of paramount importance when developing products for the treatment of COVID-19 patients and can make or break the success of a clinical trial. In our nearly 25 years of experience supporting clients worldwide in developing their products, we have a proven track record of completing complex projects within the agreed timelines. Based upon our expertise coupled with our recent involvement with clients who have started COVID-19 related projects, we are pleased to provide some key elements to consider when setting up your COVID-19 project for success.
Supporting the Fight against COVID-19
With nearly 25 years of clinical research experience, CROMSOURCE knows the most efficient ways to run a clinical trial. We have a dedicated COVID-19 Expert Team guiding our clients to navigate this challenging and changing landscape. Based on our broad expertise combined with our cutting-edge technological support, we are able to help our clients fight this pandemic from different angles by being involved in the research of vaccines, diagnostics and therapeutic agents.
Rapid study start-up is of paramount importance when developing products for the treatment of COVID-19 patients. For one of our Clients, we have been able to achieve a very important milestone by getting their sites up ready in record time. Read more in this article.
Latest Press Release
We are very proud to report our support of the COVID-19 trial in Italy on behalf of a European pharmaceutical company.
This trial is expected to be performed in Italy, though additional studies are planned by CROMSOURCE for other countries in Europe as well as the United States.
Work from home
Tips for working from home
Staying productive while working from home during a pandemic can be a challenge. We asked our tenured work from home colleagues their advice on how they stay focused and keep balance while working from home.
Check out some of the great tips they offered!